Body composition correlates with laboratory parameters and disease severity in infants with biliary atresia

Luba Marderfeld1,2, Orith Waisbourd-Zinman1,3, Neta Biran1,2

  • 1Institute of Gastroenterology, Nutrition and Liver Diseases, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.

Pediatric Transplantation
|December 20, 2021
PubMed

Insights

Malnutrition is common in infants with biliary atresia (BA). Mid-upper arm circumference (MUAC) best reflects disease severity and bilirubin levels, though further research on fat mass (FM) assessment is needed.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Nutritional Science

Background:

  • Infants with biliary atresia (BA) frequently experience chronic malnutrition.
  • Optimal anthropometric measures for assessing malnutrition and its link to BA severity are not well-established.

Purpose of the Study:

  • To evaluate correlations between various anthropometric measurements (including air displacement plethysmography - ADP) and laboratory parameters in infants with BA.
  • To assess the relationship between anthropometric data and the pediatric end-stage liver disease (PELD) score in infants with BA.

Main Methods:

  • Nutritional assessments including dietary intake, weight, height, mid-upper arm circumference (MUAC), and skin-fold thickness were conducted.
  • Fat-free mass (FFM) and fat mass (FM) were measured using ADP in infants with BA.

Main Results:

  • Most infants with BA exhibited malnutrition across various anthropometric assessments.
  • A low MUAC-Z score was significantly associated with higher PELD scores and higher serum bilirubin levels.
  • Fat mass (FM) correlated with skin-fold thickness-Z and was low in most patients, but did not correlate with PELD or bilirubin levels.

Conclusions:

  • Mid-upper arm circumference (MUAC) is a valuable anthropometric indicator for assessing malnutrition and correlating with disease severity in infants with biliary atresia (BA).
  • Further investigation is required to determine the utility of fat mass (FM) measurements by ADP in the anthropometric evaluation of infants with BA.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
16
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
10
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
15
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
15
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
678